Vistagen Therapeutics, Inc. (VTGN)
0.5575
-0.01
(-1.01%)
USD |
NASDAQ |
Feb 09, 16:00
0.5575
0.00 (0.00%)
After-Hours: 18:12
Vistagen Therapeutics EPS Diluted (Quarterly) : -0.5432 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| XOMA Royalty Corp. | 0.6991 |
| Omeros Corp. | -0.4666 |
| GeoVax Labs, Inc. | -7.787 |
| Daré Bioscience, Inc. | -0.2793 |
| Spero Therapeutics, Inc. | -0.1312 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.42M |
| Revenue (Quarterly) | 0.258M |
| Total Expenses (Quarterly) | 19.68M |
| Enterprise Value | -53.07M |
| Gross Profit Margin (Quarterly) | 28.29% |
| Profit Margin (Quarterly) | -7.53K% |
| Earnings Yield | -340.4% |
| Normalized Earnings Yield | -340.38 |